Green synthesis of gold nanoparticles using Euphrasia officinalisleaf extract to inhibit lipopolysaccharide-induced inflammation through NF-κB and JAK/STAT pathways in RAW 264.7 macrophages

Abstract

Background

Gold nanoparticles (AuNPs) have potential applications in the treatment and diagnosis process, which are attributed to their biocompatibility and high efficiency of drug delivery. In the current study, we utilized an extract of Euphrasia officinalis, a traditional folk medicine, to synthesize gold nanoparticles (EO-AuNPs), and investigated their anti-inflammatory effects on lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages.

Materials and methods

The AuNPs were synthesized from an ethanol extract of E. officinalis leaves and characterized using several analytical techniques. Anti-inflammatory activities of EO-AuNPs were detected by a model of LPS-induced upregulation of inflammatory mediators and cytokines including nitric oxide (NO), inducible nitric oxide synthase (iNOS), tumor necrosis factor-α (TNF-α), IL-1β, and IL-6 in RAW 264.7 cells. The activation of nuclear factor (NF)-κB and Janus kinase/signal transducer and activators of transcription (JAK/STAT) signaling pathways was investigated by Western blot.

Results

The results confirmed the successful synthesis of AuNPs by E. officinalis. Transmission electron microscopy images showed obvious uptake of EO-AuNPs and internalization into intracellular membrane–bound compartments, resembling endosomes and lysosomes by RAW 264.7 cells. Cell viability assays showed that EO-AuNPs exhibited little cytotoxicity in RAW 264.7 cells at 100 µg/mL concentration after 24 hours. EO-AuNPs significantly suppressed the LPS-induced release of NO, TNF-α, IL-1β, and IL-6 as well as the expression of the iNOS gene and protein in RAW 264.7 cells. Further experiments demonstrated that pretreatment with EO-AuNPs significantly reduced the phosphorylation and degradation of inhibitor kappa B-alpha and inhibited the nuclear translocation of NF-κB p65. In addition, EO-AuNPs suppressed LPS-stimulated inflammation by blocking the activation of JAK/STAT pathway.

Conclusion

The synthesized EO-AuNPs showed anti-inflammatory activity in LPS-induced RAW 264.7 cells, suggesting they may be potential candidates for treating inflammatory-mediated diseases.

Introduction

Inflammation is an immune system’s defensive response to harmful stimuli, such as pathogens, damaged cells, toxic compounds, or irradiation, which acts by removing injurious stimuli and initiating the healing process. Prolonged and severe inflammatory responses may give rise to many progressive diseases, including cancer, cardiovascular disease, diabetes, and autoimmune conditions.¹ As part of the innate immune system, macrophages are commonly applied to investigate immunoregulatory and anti-inflammatory agents. Lipopolysaccharide (LPS), the major component of the outer cell membrane of Gram-negative bacteria, can activate macrophages and produce large amounts of pro-inflammatory mediators and cytokines, including nitric oxide (NO), tumor necrosis factor (TNF)-α, IL-1β, and IL-6.¹ NO is an unorthodox messenger molecule, which can be generated by inducible nitric oxide synthase (iNOS) in LPS-stimulated macrophages.² LPS is also recognized by the immune system as a marker for the detection of bacterial pathogen invasion that is responsible for the development of inflammatory response and, in extreme cases, endotoxic shock. Studies show that regulation of the production of these mediators and cytokines can effectively control inflammation.³ Anti-inflammatory drugs reduce pain, decrease fever, prevent blood clots, and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.⁴ We need to apply natural anti-inflammatory factors within medication therapy to achieve an increased pharmacological response and the lowest degree of unwanted side effects. Therefore, medicinal plants and their secondary metabolites are progressively being used in the treatment of diseases as complementary medicines.⁵

LPS works as a pathogen-associated molecular pattern and binds to the Toll-like receptor 4 (TLR4) of host cells.⁶ Activated TLR4 recruits downstream factors and initiates intracellular signaling cascades. Nuclear factor kappa B (NF-κB) is a redox-sensitive transcription factor that is responsible for the expression of pro-inflammatory genes.⁷ NF-κB is sequestered by inhibitor kappa B-alpha (IκBα) within the cytoplasm of unstimulated cells. LPS activates the inhibitor kappa B kinase complex, resulting in the ubiquitination and subsequent degradation of IκBα, allowing NF-κB to translocate to the nucleus and induce the expression of target genes.⁸ The Janus kinase/signal transducer and activators of transcription (JAK/STAT) pathway is also critical for mediating inflammatory responses. With the binding of LPS to their receptors, the receptor-associated tyrosine kinase family of JAKs becomes activated, which consequently leads to the phosphorylation of STAT1. In turn, STAT1 translocates into the nucleus, where it acts as a transcription factor, inducing iNOS expression and enhancing NO production.⁹

Due to their ease of synthesis, functionalization, and biocompatibility, nanoparticles (NPs) have been widely applied in nanomedicine and biomedical applications, such as drug delivery, cancer treatment, virus detection, anti-inflammatory activity, and immunosuppressive effects; they have also been used actively in the identification of chemical and biological agents.^10–12 Recently, much attention has been paid to exploring protein or peptide-mediated biomimetic NPs because of the advantages of high bioactivity efficacy, enhanced biocompatibility, and less side effects on health tissues.^13–15 Although nanotechnology and nanomaterials have been widely developed, the toxicity for health tissues and cells was one of the main therapeutic efficiency-limiting challenges.¹⁶ Compared with other metal-based NPs such as silver, zinc oxide, and iron oxide, gold nanoparticles (AuNPs) usually show relatively low toxicity, as its core is inert and nontoxic.^16,17 A variety of methodologies for NP synthesis, including chemical, thermal, electrochemical, and sonochemical pathways, have so far been developed.¹⁸ In addition, plant extracts, bacteria, and fungi, among others, have been considered as potential materials for the biosynthesis of AuNPs.¹⁹ Importantly, natural plants used to mediate synthesis have been proven to have a double effect, acting both as reducing and capping agents and then improving the pharmacological activity and stability of AuNPs in a synergistic manner.²⁰ The plant-mediated synthesis of metallic NPs is an increasing commercial demand due to its wide applicability in various areas such as electronics, catalysis, chemistry, energy, cosmetics, and medicine. In the current study, we used an extract of Euphrasia officinalis for the green synthesis of AuNPs and investigated its anti-inflammatory function.

E. officinalis, commonly known as eyebright, is an important medicinal plant in the genus Euphrasia, belonging to the Orobanchaceae family. It has been widely used in Europe as an anti-inflammatory agent for hay fever, sinusitis, and upper respiratory tract infections,²¹ and especially as an eye lotion to treat and prevent eye disorders such as conjunctivitis, ophthalmia, ocular allergies, and eye fatigue.^22,23 In our previous study, an ethanol extract of E. officinalis leaf showed the presence of phenolic acids (caffeic acid) and flavonoids (luteolin-glucoside and rutin).²⁴ These compounds are known to act as reducing agents and stabilizers in the bioreduction of gold salt.^25,26 Moreover, it has been reported that E. officinalis extracts have antioxidant, anti-inflammatory, and antimicrobial activities.^22,27 Considering the biological functions ofE. officinalis, we used it to synthesize AuNPs in an eco-friendly and economical way. Once synthesized, the AuNPs were thoroughly characterized using many physicochemical techniques. Finally, we investigated the effects of the synthesized E. officinalis-AuNPs (EO-AuNPs) on LPS-induced inflammation in RAW 264.7 murine macrophages.

Materials and methods

Materials and chemicals

LPS (from Escherichia coli 0111:B4), gold (III) chloride trihydrate (HAuCl₄⋅3H₂O), 2,2-diphenyl-1-picrylhydrazyl, MTT, dimethyl sulfoxide (DMSO), and all other chemicals were purchased from Sigma-Aldrich Chemicals (St Louis, MO, USA). DMEM, FBS, penicillin-streptomycin, and 0.5% trypsin-ethylenediaminetetraacetic acid were all purchased from Thermo Fisher Scientific (Waltham, MA, USA). All of the other chemicals and reagents used in this study were of reagent-grade quality and available commercially.

Preparation of E. officinalis extract

The dried leaf of E. officinalis was purchased from Mountain Rose Herbs (Eugene, OR, USA). The preparation of E. officinalis leaf extract was performed in our lab as described previously.²⁴ First, 10 g of dried E. officinalis leaf powder was thoroughly suspended in 50 mL of 95% ethanol for 24 hours at 37°C. This procedure was repeated for three-times, and then the combined extracts were filtered and completely evaporated using a rotary vacuum evaporator at 40°C and finally stored at 4°C. The dried extract was dissolved in sterile water and filtered through a 0.22 µm filter before use.

Green synthesis of EO-AuNPs

For the synthesis of EO-AuNPs, 5 mg of E. officinalis leaf extract was dissolved in 10 mL of sterile water and passed through a 0.22 µm filter before use. Gold salt was added with a final concentration of 1 mM in the reaction mixtures. The reaction mixtures were incubated in a shaking incubator for 3 hours at 200 rpm and 37°C. A color change was observed visually, indicating the formation of AuNPs in the reaction mixtures. The suspension was first centrifuged at 3,500 rpm for 10 minutes to remove the unreacted plant extract. Next, the biosynthesized NPs were collected by centrifugation at 12,000 rpm for 20 minutes and further purified by continuous washing with sterile distilled water to obtain NPs in pellet form. Finally, the purified NPs were suspended in distilled water or air-dried overnight for further study.

Characterization of EO-AuNPs

The absorbance spectra of the purified NP suspension were scanned in the wavelength range of 300–800 nm using an ultraviolet-visible light spectrophotometer (UV-vis, Cary 60; Agilent, Santa Clara, CA, USA). The morphology, purity, structure, and elemental distribution of the EO-AuNPs were observed by transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDX), selected area electron diffraction (SAED), and elemental mapping analysis with a JEM-2100F (JEOL, Tokyo, Japan) instrument operated at 200 kV. TEM images were obtained by placing droplets of the purified NPs suspended in water on a carbon-coated copper grid and drying them at room temperature before microscopic analysis.

Powder X-ray diffraction (XRD) patterns were obtained using a diffractometer (D8 Advance; Karlsruhe, Bruker, Germany) operating at 40 kV and 40 mA, with CuKα radiation, a scanning rate of 6°/min, and a step size of 0.02° over the 2θ range of 20°–80°. The zeta potential of EO-AuNPs suspended in distilled water was determined using a Zeta-Potential Analyzer (ELS-Z2; Otsuka Electronics Co. Ltd., Osaka, Japan) at 25°C.

Fourier-transform infrared (FTIR) spectra of air-dried EO-AuNPs were acquired by a Spectrum™ One FTIR Spectrometer (PerkinElmer, Waltham, Massachusetts, USA) from 4,000–450 cm⁻¹ and at a resolution of 4 cm⁻¹ on KBr pellets. FTIR analysis was employed to identify the possible functional groups of the plant extract capped on the surfaces of the AuNPs.

Cell culture

Murine macrophages (RAW 264.7) were obtained from the Korean Cell Line Bank (Seoul, Republic of Korea). Cells were cultured in DMEM supplemented with 10% heat-inactivated FBS and 1% penicillin-streptomycin at 37°C in a 5% CO₂ humidified incubator.

Enhanced dark-field microscopy system

RAW 264.7 cells were seeded onto 18 mm coverslips at a density of 1×10⁵ cells/mL overnight at 37°C in a 5% CO₂ humidified incubator, and were then treated with 80 µg/mL of EO-AuNPs. After 3 hours of incubation, the cell medium was removed, and the cells were rinsed three times with PBS to remove the unbound NPs. The coverslips were placed on the slides and sealed using clear fingernail polish. The EO-AuNPs associated with cells were then observed via resonant light scattering using a lab-made wavelength-dependent enhanced dark-field microscopic system, which was an enhanced dark-field (EDF) illumination system (CytoViva Inc., Auburn, AL, USA) attached to an upright Olympus BX51 microscope (Olympus Optical Co., Ltd., Tokyo, Japan).²⁸

Transmission electron microscopy analysis

RAW 264.7 cells were seeded at a density of 1×10⁵ cells/well in a six-well plate overnight at 37°C with 5% CO₂ and then were treated with EO-AuNPs (40 and 80 µg/mL). After 3 hours of incubation, the cell media were discarded and the cells were rinsed three times with PBS to remove the unbound NPs. Cell pellets were fixed with 2.5% glutaraldehyde for 8 hours, post-fixed with 1% osmium tetroxide for 2 hours, and dehydrated through an ethanol series (50%, 70%, and 90% for 15 minutes each, and 100% for 15 minutes twice). The samples were embedded in propylene oxide: Epon (2:1, 50°C for 1 day and 60°C for 2 days). Ultrathin sections (70 nm) were cut using an ultramicrotome (Leica EM UC7, Wetzlar, Germany), placed on the grids, stained with 3% uranyl acetate and lead citrate, and imaged using an 80 kV JEM-1010 TEM (JEOl, Tokyo, Japan).

Cell viability assay

The cytotoxicity of EO-AuNPs against RAW 264.7 macrophages was analyzed by the MTT assay. RAW 264.7 cells were seeded at a density of 1×10⁵ cells per well in a 96-well culture plate (containing 100 µL of culture medium) for 24 hours of incubation. When they reached 90% confluence, cells were treated with various concentrations of EO-AuNPs (10–100 µg/mL). After 24 hours of incubation, 100 µL of MTT solution at a final concentration of 0.5 mg/mL was added to each well and further incubated for 3 hours. Finally, 100 µL of DMSO was added to dissolve the formazan crystals. The absorbance of each well was measured at 570 nm using a microplate reader (Filter Max F5; Molecular Devices, San Francisco, CA, USA). Blank values were subtracted from experimental values.

Nitric oxide analysis

RAW 264.7 cells were seeded at a density of 5×10⁴ cells/well in a 96-well plate (containing 200 µL of culture medium) in triplicate and then pre-incubated with various concentrations (10–100 µg/mL) of EO-AuNPs before stimulation with or without LPS (1 µg/mL) for 24 hours. Then, 100 µL of supernatant of cultured medium was transferred to a corresponding well in another plate and mixed with 100 µL of Griess reagent. After 10 minutes of incubation at room temperature, the absorbance was measured at 570 nm. Finally, the concentration of nitrite was calculated from a standard sodium curve.

Analysis of pro-inflammatory cytokine production

RAW 264.7 macrophages (1×10⁵ cells/well) were seeded in 24-well plates. The cells were pretreated with various concentrations of EO-AuNPs for 1 hour, followed by stimulation with 1 µg/mL LPS for 6 hours. Subsequently, super-natants were collected from the cell media to measure the production of TNF-α, IL-1β, and IL-6 using an ELISA according to the manufacturer’s instructions (R&D Systems, Minneapolis, MN, USA).

Reverse transcription-PCR (RT-PCR) analysis

Total RNA was extracted from RAW 264.7 cells using a Trizol reagent kit (Thermo Fisher Scientific), carefully following the manufacturer’s instructions. First, 2 µg of total RNA was used as a template to make the first strand of cDNA using the AccuPower RT PreMix (Bioneer, Daejeon, Republic of Korea) and then 1 µL of the cDNA mixture was used for enzymatic amplification. The PCR was performed using the AccuPower HotStart PCR PreMix (Bioneer). The primers used in this study were as follows: iNOS, forward 5′-CCCTTCCGAAGTTTCTGGCAGCAGC-3′ and reverse 5′-GGCTGTCAGAGAGCCTCGTGGCTTTGG-3′; and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), forward 5′-ACCACAGTCCATGCCATCAC-3′ and reverse 5′-CCACCACCCTGTTGCTGTAG-3′. The PCR products were separated by performing 2.0% agarose gel electrophoresis, stained with ethidium bromide, and detected by using UV transilluminator. The housekeeping gene GAPDH was used as an internal control. All the real-time experiments were performed in triplicate, and statistical analysis was carried out using Student’s t-tests.

Western blot analysis

RAW 264.7 cells at 5×10⁵ cells/well were plated in 60 mm dishes for 24 hours and then incubated with various concentrations (10–100 µg/mL) of EO-AuNPs and LPS (1 µg/mL) for 6 hours. After being washed with PBS, cell pellets were collected by centrifugation and lysed using cell RIPA lysis buffer for 1 hour. The cell lysates were centrifuged at 12,000 rpm for 20 minutes at 4°C, and the protein content was quantified using the Bradford reagent (Sigma-Aldrich Co.). Equal amounts (50 µg) of total protein were loaded in 10% SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked with 5% skim milk or BSA at room temperature for 1 hour and then incubated with primary antibodies against iNOS, IκBα, p-IκBα, NF-κB p65, JAK1, p-JAK1, STAT1, p-STAT1, STAT3, p-STAT3, β-actin, and histone for overnight at 4°C. After being washed three times with Tris-buffered saline-Tween 20 (0.1%), the membranes were incubated with respective secondary antibodies conjugated with horseradish peroxidase (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) for 1 hour. The immunoreactive bands were visualized with an enhanced chemiluminescence detection system (Fujifilm, LAS-4000, Tokyo, Japan) and normalized to the β-actin expression on the same membrane.

Statistical analysis

Experimental data are reported as mean ± standard errors of the mean. Statistical analysis was performed using GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, CA, USA). Statistical significance was evaluated using one-way ANOVA followed by Dunnett’s multiple comparison test. P<0.05, P<0.01, and P<0.001 were considered to be statistically significant.

Results

Synthesis and characterization of EO-AuNPs

The ethanol extract ofE. officinalis leaf exhibited the ability of reducing HAuCl₄⋅3H₂O to result in the synthesis of AuNPs. UV-vis spectroscopy over the range of 350–800 nm resulted in a strong absorption peak at 540 nm, which corresponded to the surface plasmon resonance (SPR) band of the formed AuNPs (Figure 1A). In addition, a visible color change was also observed in the reaction mixture from light yellow to deep purple. These results clearly confirmed the synthesis of AuNPs fromE. officinalis leaf extract.

Figure 1.

(A) UV–vis spectra and (B) TEM images of EO-AuNPs.

Abbreviations: UV–vis, ultraviolet-visible; E. officinalis, Euphrasia officinalis; EO-AuNPs, E. officinalis-gold nanoparticles; TEM, transmission electron microscopy; SPR, surface plasmon resonance.

A TEM image of EO-AuNPs is shown in Figure 1B, which reveals a majority of spherical or hexagonal shapes with lattice fringes and a few triangular-shaped NPs with sizes varying from 5 to 30 nm. Elemental mapping indicated the distribution of elemental gold in the bioreduced NPs (Figure 2A and B). The distribution of gold was visible in the electron image, suggesting that gold was the predominant element in the NPs. EDX analysis of EO-AuNPs (Figure 2C) showed a strong optical absorption peak at 2.3 keV, which corresponded to the characteristic peak of elemental gold. The other metal group recorded at 8 keV corresponded to the copper grid utilized for study. The SAED pattern indicated the diffraction pattern of multiple particles and metallic nature of the synthesized EP-AuNPs (Figure 2D). In addition, similar results were documented in the XRD analysis. As shown in Figure 2E, four characteristic peaks of gold were indexed to the (111), (200), (220), and (311) lattice planes of Bragg’s reflection, and four diffraction peaks were displayed at the 2θ values of 38.11°, 45.15°, 64.65°, and 77.93°. The zeta-potential value of EO-AuNPs revealed the stability of NPs in suspension form with a negative surface net charge of −39.9 mV (data not shown).

Figure 2.

(A and B) Elemental mapping, (C) EDX spectrum, (D) XRD, and (E) SAED pattern of EO-AuNPs.

Abbreviations: EDX, energy-dispersive X-ray; XRD, X-ray diffraction; SAED, selected area electron diffraction; EO-AuNPs,Euphrasia officinalis-gold nanoparticles.

The FTIR spectra of the E. officinalis leaf extract and EO-AuNPs revealed bands at 3,326.32 and 3,385.65 cm⁻¹corresponding to the O−H stretching, those at 2,922.84, 2,920.18, 2,852.79, and 2,850.47 cm⁻¹ corresponding to the C−H stretching, at 1,735.49–1,508.68 cm⁻¹ corresponding to the C=O and aromatic C=C double-bond functional groups, in the range from 1,458.79 to 1,024.28 cm⁻¹ corresponding to aromatic C−C groups and C−O functional groups, and those at 810.94, 713.20, and 722.12 cm⁻¹ corresponding to the deformation vibration of C−H bonds in the phenolic rings (Figure 3).^29–31

Figure 3.

FTIR analysis of synthesized EO-AuNPs and plant extract of E. officinalis.

Abbreviations: FTIR, fourier-transform infrared; E. officinalis, Euphrasia officinalis; EO-AuNPs, E. officinalis-gold nanoparticles.

Evaluation of nanoparticle uptake and intracellular localization

To visualize the NPs’ uptake ability, macrophages were incubated with EO-AuNPs for two different time durations (5 minutes and 3 hours). We first performed bright-field microscopy to locate the cells, and then switched to EDF microscopy for analysis. As shown in Figure 4, the uptake of NPs was very fast, starting at 5 minutes after being added to the RAW 264.7 macrophages. After 3 hours of incubation, there appeared to be better uptake that was intracellularly localized, likely in the form of aggregates, as shown by the bright white spots inside the macrophages.

Figure 4.

Uptake of EO-AuNPs by RAW 264.7 cells observed with an enhanced dark-field (EDF) microscopy. Cells were incubated with EO-AuNPs (80 µg/mL) for 5 minutes and 3 hours and then were observed by EDF illumination system. The bright white spots inside the macrophages represent the aggregation of EO-AuNPs.

Abbreviations: DIC, differential interference contrast; TIRS, thermal infrared sensor; EO-AuNPs, Euphrasia officinalis-gold nanoparticles.

Further evidence supporting the intracellular localization of the EO-AuNPs was acquired via TEM. Previous studies have demonstrated the endocytotic uptake of the NPs in both monocytes and macrophages regarding both the adsorptive step on the plasma membrane and the further localization in the lysosomes.³² Our findings also suggest that clustered EO-AuNPs were detected outside of the cell membrane and also within the intracellular compartments resembling phagosomes and lysosomes (Figure 5).

Figure 5.

Intracellular localization of EO-AuNPs in RAW 264.7 cells observed by a transmission electron microscopy (TEM). Cells were treated with EO-AuNPs (40 and 80 µg/mL) for 3 hours and then were fixed and examined by TEM (scale bar =1 µm). EO-AuNPs are distributed in the membrane-bound compartments, resembling endosomes or lysosomes.

Abbreviations: N, nucleus; Mi, mitochondria; ER, endoplasmic reticulum; En, endosome; Ly, lysosome; EO-AuNPs, Euphrasia officinalis-gold nanoparticles.

Effect of EO-AuNPs on cell viability

The potential cytotoxicity of EO-AuNPs in RAW 264.7 macrophages was investigated by MTT assay. EO-AuNPs were evaluated at concentrations ranging from 20 to 100 µg/mL. As shown in Figure 6A, EO-AuNPs did not exhibit cytotoxicity against RAW 264.7 cells at the concentrations from 20 to 80 µg/mL. However, 25.5% cell death was caused at the concentration of 100 µg/mL.

Figure 6.

Effect of EO-AuNPs on LPS-induced inflammatory mediators production in RAW 264.7 cells. (A) Cell viability was measured by MTT assay. (B) The concentration of NO in medium was measured by Griess method. (C–E) The production of TNF-α, IL-1β, and IL-6 in medium was measured using ELISA kits. Data are representative of three independent experiments and values are shown as mean ± SEM. *P<0.05, **P<0.01, ***P<0.001 compared to non-treated control. ^#P<0.05, ^##P<0.01, ^###P<0.001 compared to the LPS control.

Abbreviations: TNF-α, tumor necrosis factor-α; EO-AuNPs, Euphrasia officinalis-gold nanoparticles; LPS, lipopolysaccharide; NO, nitric oxide; SEM, standard error of the mean.

Effect of EO-AuNPs on NO production

To determine whether EO-AuNPs could inhibit NO production in LPS-stimulated RAW 264.7 cells, we determined the levels of nitrite, which is a stable product of NO metabolism, in the culture media using the Griess reagent. Exposure to LPS (1 µg/mL) for 24 hours markedly induced excess release of NO (Figure 6B). The increase of NO production was significantly suppressed by EO-AuNPs in a concentration-dependent manner. However, given that a 100 µg/mL concentration of EO-AuNPs caused cytotoxicity in RAW 264.7 cells, EO-AuNPs concentrations from 40 to 80 µg/mL exhibited significant inhibition of LPS-induced NO production without obvious toxicity.

Effects of EO-AuNPs on the production of pro-inflammatory cytokines

Pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6, are of great importance in the inflammatory process. To further estimate the effects of EO-AuNPs on inflammation, the production of these cytokines in LPS-treated macrophages was measured by ELISA. As shown in Figure 6C–E, the LPS-induced TNF-α, IL-1β, and IL-6 releases were significantly blocked by the EO-AuNPs in a dose-dependent manner.

Effects of EO-AuNPs on iNOS gene and protein expression

To determine whether the anti-inflammatory effects of EO-AuNPs are involved in the suppression of NO, the production of iNOS induced by LPS in RAW 264.7 cells was measured by RT-PCR and Western blot methods. The RAW 264.7 cells were treated with or without various concentrations (40, 60, and 80 µg/mL) of EO-AuNPs and 1 µg/mL of LPS for 24 hours. Significant increases in the iNOS mRNA (Figure 7A and B) and protein (Figure 7C and D) were shown by LPS-stimulated RAW 264.7 macrophages. However, EO-AuNPs obviously suppressed the expression of the iNOS gene and protein in a dose-dependent manner, demonstrating the inhibitory effect of EO-AuNPs on iNOS transcriptional events in LPS-stimulated macrophages.

Figure 7.

Effect of EO-AuNPs on LPS-induced iNOS expression in RAW 264.7 cells. (A and B) mRNA expression of iNOS was determined by RT-PCR analysis and normalized to the corresponding value of GAPDH. (C and D) Protein expression of iNOS was determined by Western blot analysis and normalized to the corresponding value of β-actin. Densitometry data are expressed as percentage relative to the non-treated control and shown as mean ± SEM. **P<0.01 compared to the non-treated control. ^#P<0.05, ^##P<0.01 compared to the LPS control.

Abbreviations: iNOS, inducible nitric oxide synthase; EO-AuNPs, Euphrasia officinalis-gold nanoparticles; LPS, lipopolysaccharide; RT-PCR, reverse transcription-PCR; SEM, standard error of the mean; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

Effects of EO-AuNPs on the NF-κB signaling pathway

Under inactive conditions, the NF-κB dimer is bound to its inhibitory protein IκBα in the cytoplasm. Once stimulated by LPS, the phosphorylated IκBα is ubiquitinated and degraded, resulting in the nuclear translocation of NF-κB, which leads to the transcription of inflammatory genes such as TNF-α, IL-1β, and IL-6.³³ In the present study, RAW 264.7 cells were incubated with EO-AuNPs at various doses for 1 hour, followed by LPS (1 µg/mL) treatment for 4 hours. As shown in Figure 8A and B, pretreatment with EO-AuNPs distinctly blocked the LPS-induced upregulation of the phosphorylation and degradation of the IκBα protein. In addition, we found that LPS treatment showed an enhancement of nuclear NF-κB and a reduction of cytosolic NF-κB (Figure 8C and D). However, pretreatment with EO-AuNPs reduced the protein expression of the nuclear NF-κB p65 subunit. Therefore, the results demonstrated that EO-AuNPs significantly inhibited the translocation of NF-κB from the cytoplasm to the nucleus in LPS-stimulated RAW 264.7 cells.

Figure 8.

Effect of EO-AuNPs on NF-κB signaling-related protein expression in RAW 264.7 cells. (A and C) The proteins of cytosolic p-IκBα, IκBα, and nuclear NF-κB p65 in LPS-stimulated RAW 267.4 cells were measured by Western blot analysis. The band intensities for (B and D) p-IκBα, IκBα, and nuclear NF-κB p65 were quantified and normalized to the corresponding value of β-actin and histone. Densitometry data are expressed as percentage relative to the non-treated control and shown as mean ± SEM. *P<0.05, **P<0.01, ***P<0.001 compared to the non-treated control. ^#P<0.05, ^##P<0.01, ^###P<0.001 compared to the LPS control.

Abbreviations: NF-κB, nuclear factor kappa-B; p-IκBα, phosphorylated inhibitor kappa B-alpha; EO-AuNPs, Euphrasia officinalis-gold nanoparticles; LPS, lipopolysaccharide; SEM, standard error of the mean.

Effects of EO-AuNPs on the JAK/STAT signaling pathway

The LPS-stimulated activation of JAK/STAT signaling plays an important role in inflammatory responses. We therefore determined several crucial transcription factors to investigate whether EO-AuNPs suppressed the activation of JAK/STAT signaling in LPS-stimulated RAW 264.7 macrophages. As shown in Figure 9, EO-AuNPs dramatically attenuated the upregulation of the phosphorylation of STAT1 and STAT3 in a dose-dependent manner. Moreover, the LPS-induced phosphorylation of JAK1 was decreased by the EO-AuNPs.

Figure 9.

Effect of EO-AuNPs on JAK/STAT signaling-related protein expression in RAW 264.7 cells. (A) The proteins of p-JAK1, JAK1, p-STAT1, STAT1, p-STAT3, and STAT3 in LPS-stimulated RAW 267.4 cells were measured by Western blot analysis. (B–D) The band intensities for p-JAK1/JAK1, p-STAT1/STAT1, and p-STAT3/STAT3 were quantified and normalized to the corresponding value of β-actin. Densitometry data are expressed as percentage relative to the non-treated control and shown as mean ± SEM. **P<0.01, ***P<0.001 compared to the non-treated control. ^#P<0.05, ^##P<0.01, ^###P<0.001 compared to the LPS control.

Abbreviations: JAK, Janus kinase; STAT, signal transducer and activators of transcription; EO-AuNPs, Euphrasia officinalis-gold nanoparticles; LPS, lipopolysaccharide; SEM, standard error of the mean.

Discussion

AuNPs are extensively used in the biomedical field to treat various medical diseases such as cancer, inflammatory diseases, and immune system disorders, owing to their unique physicochemical and optical properties. Rapid biosynthesis of NPs was observed in different shapes (twinning, mixed structures, and dislocations), and sizes of NPs were increased by using high concentrations of plant extract.³⁴

The ease of AuNP functionalization provides a versatile platform, and bioconjugates of AuNPs have also become promising candidates in the design of novel biomaterials for the investigation of biological systems.³⁵ AuNPs have anti-inflammatory properties through their ability to hinder the expression of inflammatory reactions; recently, the anti-inflammatory effects of AuNPs have been reported in LPS-activated murine macrophage cells,³⁶ a rat alcohol-methamphetamine-induced liver injury model,³⁷ a mesentery microcirculation model, and a mouse high-fat diet-induced obesity model.³⁸ Crucially, these AuNPs were synthesized using naturally occurring bioactive compounds or extracts of medicinal plants as reductants, which have the advantages of reducing toxicity and improving biocompatibility and pharmacological activity. NPs can be synthesized by several chemical and physical methods, but the use of such methods is harmful in one way or another. The photosynthesis of NPs is emerging as the intersection of nanotechnology and biotechnology. Due to a growing need to develop environmentally benign technologies in material synthesis, it has received increased attention. In the present study, we synthesized EO-AuNPs using an ethanol extract of E. officinalis as a green reductant. It has been previously suggested that once the AuNPs are synthesized in a reaction mixture, the visual color changes to a ruby red or deep purple due to the SPR.³⁹ The reaction mixture was visually detected by the color change from light yellow to deep purple, clearly indicating that the ethanol extract ofE. officinalis had the capacity to reduce HAuCl₄⋅3H₂O to synthesize the AuNPs. Next, the particle size, shape, and crystalline nature of the synthesized EO-AuNPs were characterized using UV-vis spectroscopy, TEM, EDX, XRD, and FTIR analyses. As shown in the UV-vis absorption spectra of the reaction mixtures, there was a disappearance of the extract peak at λ_max=410 nm and the appearance of a new peak at λ_max=540 nm, which corresponds to the characteristic SPR phenomena of AuNPs.⁴⁰ TEM showed particles about 5–30 nm in size and surface morphologies with spherical, hexagonal, and triangular-shaped gold NPs, and these unique features have also been reported previously.⁴¹ EDX and XRD analyses also confirmed the presence of AuNPs and their typical metallic gold nano-crystalline structural patterns. The intense peaks present in the FTIR spectra of the EO-AuNPs revealed that the hydroxyl groups of phenolic compounds might contribute to bioreducing and capping for the synthesis of AuNPs.³⁹

E. officinalis has been traditionally used for treating inflammatory-linked diseases, such as eye disorders, colds, coughs, and hay fever.²⁷ Our previous results showed that the caffeic acid, luteolin-glucoside, rutin, and acteoside were tentatively identified by Ultra-High Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry analysis.²⁴ Till now, there is no report about physicochemical study of the EO-AuNPs and their cellular uptake pattern. In the present study, the synthesized EO-AuNPs were demonstrated to exhibit anti-inflammatory effects in LPS-stimulated RAW 264.7 cells. Previous studies have demonstrated that NPs could be internalized into macrophages by fluid-phase endocytosis. The overall uptake of NPs was described as a two-step process, including the binding of NPs on the cell membrane and the internalization of the reactive sites by an endocytosis pathway.³² Similarly, we found that the cellular uptake of EO-AuNPs started after 5 minutes and further localization inside the macrophages during the 3 hours of incubation was observed by an EDF microscopy system. Furthermore, TEM images of cells incubated with the AuNPs showed aggregated NPs both at the cell membrane and in primarily intracellular compartments resembling endosomes and lysosomes, while no AuNPs were found in the nuclei of macrophages. On the other hand, the cytotoxicity of AuNPs is still a matter of concern when they are used in biomedical applications. It has been suggested that AuNPs 1–2 nm in diameter were highly toxic, whereas those larger than 15 nm were comparatively nontoxic, irrespective of the cell type tested.⁴² Another report also showed that macrophages are highly tolerant to the cytotoxicity of anticancer drugs and NPs.⁴³ In this study, no obvious cytotoxicity was observed at 20–80 µg/mL concentrations of EO-AuNPs, while a concentration of 100 µg/mL exhibited little cytotoxicity (25.5% death rate) against RAW 264.7 cells. Therefore, EO-AuNP concentrations from 40 to 80 µg/mL can be used in our future work. However, the mechanism of entering into the lysosome or endosome needs to be studied clearly in our further study.

Macrophage-derived NO plays an important role in immunity and maintaining homeostasis, but all sorts of inflammation-related diseases are caused by the overproduction of NO.⁴⁴ Thus, iNOS, as a pivotal enzyme in the macrophages’ inflammatory response, has a catalytic effect on the production of NO.⁴⁵ Therefore, the regulation of NO and iNOS is very important for screening anti-inflammatory agents. In our present study, at concentrations of 40–80 µg/mL, EO-AuNPs effectively reduced LPS-induced NO overproduction and iNOS mRNA and protein expression in RAW 264.7 cells without producing any cytotoxicity. In addition to NO, various pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 have been known to be released by LPS-activated macrophages.⁴⁶ EO-AuNPs also significantly suppressed the LPS-induced secretion of TNF-α, IL-1β, and IL-6. A previous study showed that eye drops containing E. officinalis extracts exerted anti-inflammatory effects by effectively reducing the expression of IL-1β and iNOS in ultraviolet-B-irradiated corneal epithelial cells, which is consistent with the results of our study.²⁷

To explore the molecular mechanisms further, the effects of EO-AuNPs on the LPS-induced activation of inflammatory signaling pathways were assessed. The transcription factor NF-κB is of great importance for the regulation of pro-inflammatory responses. Recent studies have shown that the phosphorylation and degradation of IκBα lead to the activation of NF-κB in LPS-stimulated RAW 264.7 cells. Consequently, activated NF-κB translocates to the nucleus, where it regulates the expression of inflammatory genes.^6,47 In the present study, we found that EO-AuNPs exhibited anti-inflammatory effects by blocking the phosphorylation and degradation of IκBα protein and by suppressing NF-κB p65 nuclear translocation in LPS-challenged macrophages. Similarly, previous investigations have also proved that AuNPs decreased LPS-induced inflammatory mediators via the NF-κB signaling pathway.^39,48

The JAK/STAT signaling pathway has an important role in the control of immune responses, as maladjusted JAK/STAT signaling is associated with various immune diseases.⁴⁹ The activated STATs could translocate to the nucleus to regulate the expression of iNOS in RAW 264.7 cells.⁵⁰ Several studies have shown that NPs inhibited LPS-induced inflammatory responses in RAW 264.7 macrophages and human peripheral blood mononuclear cells through the JAK/STAT signaling pathway.^48,51 Thus, we evaluated whether EO-AuNPs could inhibit the activation of the JAK/STAT signaling pathway. In this study, EO-AuNPs were found to attenuate the LPS-stimulated phosphorylation of JAK1, STAT1, and STAT3 in RAW 264.7 macrophages.

Animal cell culture systems are regarded as sensitive indicators for exposure of nanomaterials.⁵² Preliminarily, the present study demonstrated the effects of synthesized EO-AuNPs on LPS-induced inflammation in RAW 264.7 murine macrophages. Further investigation on the anti-inflammatory role of EO-AuNPs in human cell lines and in vivo animal models is therefore warranted.

Conclusion

In summary, the ethanol extract ofE. officinalis leaves acted as a reducing and capping agent to successfully synthesize AuNPs. The synthesis of AuNPs using E. officinalis extract is useful not only because of their reduced environmental impact, but also because they can be used to produce large quantities of NPs. Physicochemical characterization confirmed the structural and chemical properties of the EO-AuNPs. In addition, we demonstrated that the EO-AuNPs decreased inflammatory mediators and cytokine production by suppressing the NF-κB and JAK/STAT activation in LPS-stimulated RAW 264.7 cells. Therefore, EO-AuNPs may be considered as a potential agent for the treatment of inflammatory disorders. A detailed study is needed to elucidate the anti-inflammatory effects of the biosynthesized AuNPs using the biomolecules present in E. officinalis extracts, which will be valuable to improve the properties of AuNPs.